Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Danaher Corp (NY:DHR)

197.09 -0.07 (-0.04%)
Official Closing Price Updated: 7:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations
From SCIEX
Via Business Wire
SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement
From SCIEX
Via Business Wire
SCIEX Sets a New Standard in Accurate Mass Quantitation With the ZenoTOF 8600 System and New Software Collaborations
From SCIEX
Via Business Wire
1 Cash-Producing Stock with Exciting Potential and 2 to Question
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
$100 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
It's Unofficially Summer. Time to Get Outside, and Talk With Decking Expert Trex CEO Bryan Fairbanks
Via The Motley Fool
Topics Artificial Intelligence World Trade
8 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Danaher, Illumina, Globalstar, and Insperity Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the major indices fell further in the afternoon (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft... 
Via StockStory
Topics Bonds Stocks
P/E Ratio Insights for Danaher
 
Via Benzinga
Market Whales and Their Recent Bets on DHR Options
 
Via Benzinga
Aldevron and Integrated DNA Technologies Manufacture World’s First mRNA-based Personalized CRISPR Therapy
From Integrated DNA Technologies
Via Business Wire
Q1 Research Tools & Consumables Earnings: Danaher (NYSE:DHR) Impresses
Looking back on research tools & consumables stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Danaher (NYSE:DHR) and its peers. 
Via StockStory
Topics Economy
How Is The Market Feeling About Danaher?
 
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
1 S&P 500 Stock with Competitive Advantages and 2 to Keep Off Your Radar
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
Revvity (RVTY) Q1 Earnings Report Preview: What To Look For
Life sciences company Revvity (NYSE:RVTY) will be reporting results tomorrow before market hours. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Market Whales and Their Recent Bets on DHR Options
 
Via Benzinga
$100 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Earnings To Watch: Avantor (AVTR) Reports Q1 Results Tomorrow
Life sciences company Avantor (NYSE:AVTR) will be reporting earnings tomorrow before market open. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence Economy World Trade
Analyst Sees Opportunity In Danaher Stock As Sentiment Improves
Danaher beat Q1 forecasts with $5.74 billion in sales and $1.88 EPS. Analyst sees upside ahead as bioprocess growth and CDMO demand improve. 
Via Benzinga
What 12 Analyst Ratings Have To Say About Danaher
 
Via Benzinga
West Pharmaceutical Services Earnings: What To Look For From WST
Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting results tomorrow before market open. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
DHR Q1 Earnings Call: Bioprocessing Momentum and Tariff Strategy Drive Guidance Above Expectations
Diversified science and technology company Danaher (NYSE:DHR) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $5.74 billion. Guidance for next quarter’s revenue... 
Via StockStory
Topics World Trade
Danaher Pricing Strategy Key To Navigating Tariff Challenges: Analyst
Danaher beat Q1 2025 estimates and analysts noted resilience despite macro pressures and China-related headwinds. 
Via Benzinga
Exploring the top movers within the S&P500 index during today's session.
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session. 
Via Chartmill
Danaher (DHR) Stock Trades Up, Here Is Why
Shares of diversified science and technology company Danaher (NYSE:DHR) jumped 6.6% in the afternoon session after the company reported impressive first quarter 2025 results, which beat analysts'... 
Via StockStory
Topics Artificial Intelligence
Wall Street Rebounds Ahead Of Tesla Earnings, Dow Adds 1,000 Points, Bitcoin Hits $91,000: What's Driving Markets Tuesday?
After Monday’s broad-based sell-off — triggered by renewed pressure from President Donald Trump on Federal Reserve Chairman Jerome Powell, raising concerns over the integrity of central bank... 
Via Benzinga
Topics Economy Government Stocks
Which S&P500 stocks are gapping on Tuesday?
Curious about the market action on Tuesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
Top S&P500 movers in Tuesday's pre-market session
Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session. 
Via Chartmill
Quest Diagnostics Posts Better-Than-Expected Earnings, Joins Pentair, 3M, Danaher And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.